Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis
- PMID: 33715061
- DOI: 10.1007/s11255-021-02831-9
Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis
Abstract
Background: Acute kidney injury represents a major adverse effect of vancomycin administration. The aim of the present study is to accumulate all biopsy-proven cases of vancomycin nephrotoxicity and assess the association of histopathological features with renal prognosis.
Methods: Medline, Scopus, CENTRAL, Web of Science, and Clinicaltrials.gov were systematically searched from inception to 29 September 2020. All case reports/series providing individual data of patients with biopsy-proven vancomycin nephrotoxicity were held eligible. A time-to-event analysis was performed evaluating the effects of histological diagnosis on renal recovery.
Results: Overall, 18 studies were included, comprising 21 patients. Acute tubulointerstitial nephritis was the predominant pattern in 9 patients and was associated with a significantly higher risk of permanent renal dysfunction (HR: 5.08, 95% CI: [1.05-24.50)] compared to acute tubular necrosis. Tubulitis and eosinophilic infiltration were the most common histopathological findings, while interstitial fibrosis was linked to significantly worse renal prognosis (HR: 5.55, 95% CI: 1.13-27.27). Immunofluorescence and electron microscopy features were non-specific. Obstruction by tubular casts composed of vancomycin aggregates and uromodulin has been identified as a new mechanism of nephrotoxicity.
Conclusions: Acute tubular necrosis and tubulointerstitial nephritis represent the main histological patterns of vancomycin-induced acute kidney injury. The presence of fibrosis in the context of interstitial inflammation may be linked to lower recovery rates and worse long-term renal outcomes. A novel cast nephropathy obstructive mechanism has been suggested, necessitating further confirmation. Large-scale studies should define the exact indications of kidney biopsy in cases with suspected vancomycin nephrotoxicity.
Keywords: Acute kidney injury; Kidney biopsy; Nephrotoxicity; Vancomycin.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review.BMC Nephrol. 2018 Mar 27;19(1):72. doi: 10.1186/s12882-018-0845-1. BMC Nephrol. 2018. PMID: 29587650 Free PMC article. Review.
-
Vancomycin nephrotoxicity: A comprehensive clinico-pathological study.PLoS One. 2024 Mar 7;19(3):e0295136. doi: 10.1371/journal.pone.0295136. eCollection 2024. PLoS One. 2024. PMID: 38452051 Free PMC article.
-
Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity.Kidney Int Rep. 2021 May 12;6(7):1912-1922. doi: 10.1016/j.ekir.2021.04.035. eCollection 2021 Jul. Kidney Int Rep. 2021. PMID: 34307986 Free PMC article.
-
Electron microscopic findings can support multiple etiologies of nephrotoxicity in renal tubules.Ultrastruct Pathol. 2020 Nov 20;44(4-6):481-488. doi: 10.1080/01913123.2020.1839152. Epub 2020 Nov 1. Ultrastruct Pathol. 2020. PMID: 33131373
-
Biopsy proven acute tubular necrosis associated with vancomycin in a child: case report and literature review.Ren Fail. 2007;29(8):1059-61. doi: 10.1080/08860220701643773. Ren Fail. 2007. PMID: 18067058 Review.
Cited by
-
Safe and effective use of vancomycin.Aust Prescr. 2025 Apr;48(2):54-59. doi: 10.18773/austprescr.2025.013. Aust Prescr. 2025. PMID: 40343139 Free PMC article. Review.
-
Healthcare data quality assessment for improving the quality of the Korea Biobank Network.PLoS One. 2023 Nov 20;18(11):e0294554. doi: 10.1371/journal.pone.0294554. eCollection 2023. PLoS One. 2023. PMID: 37983215 Free PMC article.
-
Vancomycin-Associated Acute Kidney Injury: A Narrative Review from Pathophysiology to Clinical Application.Int J Mol Sci. 2022 Feb 12;23(4):2052. doi: 10.3390/ijms23042052. Int J Mol Sci. 2022. PMID: 35216167 Free PMC article. Review.
-
Biopsy-proven granulomatous interstitial nephritis associated with vancomycin in an adult patient: a case report.J Int Med Res. 2023 Jun;51(6):3000605231180052. doi: 10.1177/03000605231180052. J Int Med Res. 2023. PMID: 37309693 Free PMC article.
-
The Effect of Dapagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats.Biomedicines. 2025 Jun 27;13(7):1582. doi: 10.3390/biomedicines13071582. Biomedicines. 2025. PMID: 40722655 Free PMC article.
References
-
- Holmes NE, Tong SYC, Davis JS, Hal SJV (2015) Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond. Semin Respir Crit Care Med 36:17–30. https://doi.org/10.1055/s-0034-1397040 - DOI - PubMed
-
- Filippone EJ, Kraft WK, Farber JL (2017) The nephrotoxicity of vancomycin. Clin Pharmacol Ther 102:459–469. https://doi.org/10.1002/cpt.726 - DOI - PubMed - PMC
-
- Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A (2012) Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol 68:1243–1255. https://doi.org/10.1007/s00228-012-1259-9 - DOI - PubMed
-
- Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH (1990) Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J Antimicrob Chemother 25:679–687. https://doi.org/10.1093/jac/25.4.679 - DOI - PubMed
-
- Bellos I, Karageorgiou V, Pergialiotis V, Perrea DN (2020) Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis. Clin Microbiol Infect 26:696–705. https://doi.org/10.1016/j.cmi.2020.03.019 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous